ERAS Program Implementation for MIPD

A Multicenter Randomized Prospective Study on Establishing an ERAS Program and Optimized Clinical Protocol for Patients Undergoing Minimally Invasive Pancreatoduodenectomy (MIPD)

To evaluate the impact of an Enhanced Recovery After Surgery (ERAS) program on postoperative recovery in patients undergoing minimally invasive pancreatoduodenectomy (MIPD)

Inclusion Criteria:

• Age ≥ 19 years, scheduled for standard minimally invasive (robotic or laparoscopic) pancreatoduodenectomy for periampullary tumors
• ECOG performance status of 0 or 1 at screening
• Able to provide written informed consent, understand study procedures, and complete patient-reported questionnaires
• ASA physical status classification I-III

Exclusion Criteria:

• Hypersensitivity to fentanyl or ropivacaine
• Cognitive impairment preventing independent use of patient-controlled analgesia or completion of questionnaires
• Major internal medical or psychiatric disorders affecting treatment response
• Severe hepatic or renal dysfunction
• Any condition deemed inappropriate for study participation by the investigator